Awareness in using MEK inhibitors for the treatment of viral infection includes whether they affect the replication cycle of normal cells and have side effects: for example, those observed in clinical cancer therapy, such as rash, fatigue, vomiting, and diarrhea. Here, MAP2K7 is linked to viral infectious disease.